Skip to content

Effect of Metformin in Acne Vulgaris

Evaluation of the effectiveness of Metformin in comparison with Doxycycline in treatment of patients with Acne Vulgaris skin disease.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201108049309N1
Enrollment
40
Registered
2022-06-07
Start date
2020-12-14
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne. Acne, unspecified

Interventions

Intervention 1: Intervention group: Intervention group: Apometformin 500 mg twice daily+ topical benzoyl peroxide 5% (pangel) on the lesions every other night for 2 months. Intervention 2: Control gro
the Intervention group: Metformin (Abidi Company) 500mg daily for 2 months +benzoyl proxide 5%gel(pangel) every other night on acne lesions.

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years

Inclusion criteria

Inclusion criteria: 16-40 years old patients with moderate acne . They should not have been treated with systemic medications since 1 month ago. They should not have been treated with topical therapy since 2 weeks ago.

Exclusion criteria

Exclusion criteria: The patients with a history of hypersensitivity to metformin and doxycycline. . Patients with systemic diseases are excluded. The patients with systemic disease The pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Acne severity. Timepoint: before treatment and 1,2 months after treatment. Method of measurement: Global acne grading system,burke and cunliffe and counting total lesion count.

Secondary

MeasureTime frame
Response to treatment. Timepoint: at the onset and 2 months after treatment. Method of measurement: asking patient himself.;Effect of acne on patient life. Timepoint: before treatment and 2 months after treatment. Method of measurement: Cardiff Acne disability index method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazafarin Yazdanpanah

Shiraz University of Medical Sciences

Nazafarin.yazdanpanah@gmail.com+98 71 3231 9049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026